Consumer health

Beyfortus
Pharma

Sanofi isn't sweating a potential RSV showdown with Merck

Despite Merck & Co. homing in on approval for its infant RSV antibody clesrovimab, Sanofi thinks Beyfortus can hold its own.
Fraiser Kansteiner Oct 25, 2024 11:12am
Marriott International CEO Arne Sorenson has been called to testify at a March 7 Senate hearing regarding data breaches in th

Pfizer, Lilly DTC platforms land in senators' crosshairs

Oct 22, 2024 3:25pm
Sanofi

Sanofi moves to sell 50% stake in €16B consumer health unit

Oct 21, 2024 11:34am
Two people sit across from each other at a desk

Activist investor Starboard picks up stake in Kenvue: WSJ

Oct 21, 2024 11:00am
strike industrial action demonstration workers rights

Sanofi workers in France move to strike over Opella sale talks

Oct 16, 2024 9:28am
Sanofi Opella Dulcolax Pooping Princesses campaign

Sanofi's Dulcolax crowns 'Pooping Princesses' to fight stigma

Oct 11, 2024 11:30am
More News

Sanofi in talks over potential sale of consumer health business

Oct 11, 2024 10:13am

Pfizer offloads another tranche of Haleon shares for £2.4B

Oct 1, 2024 10:23am

Sanofi courts offers for its consumer health business: Bloomberg

Sep 25, 2024 12:05pm

Bayer builds ‘ecosystem’ around cell health support supplement

Sep 4, 2024 12:04pm